Knee Replacement Surgery Market by Procedure Type (Knee Replacement: Total, Partial, Revision), Product (Implants: Hybrid, Plastic, Metal or Ceramic; Orthobiologic, Braces), Application (Arthritis, Cancer), End User (Clinics, ASCs) - Global Forecast to 20

The global knee replacement surgery market is expected to reach USD 16.17 billion by 2030 from USD 12.00 billion in 2025, at a CAGR of 6.1% from 2025 to 2030. The Knee replacement surgery market is witnessing substantial growth driven by several key factors. A heightened awareness of various treatment modalities, coupled with improved healthcare infrastructure in developing regions, is facilitating an increase in surgical procedures. Additionally, government initiatives and insurance reforms are enhancing both the affordability and accessibility of knee surgeries, further propelling market activity. Notably, the rising incidence of sports-related injuries among the younger population is contributing to the premature onset of knee conditions, thereby expanding the patient demographic that requires surgical intervention. Collectively, these factors are catalyzing the expansion of the global knee replacement surgery market.

“The total knee replacement segment held the largest procedure type market share in 2024.”

The knee replacement surgery market is divided into total knee replacement, partial knee replacement, revision knee replacement, and other procedure types. In 2024, the total knee replacement (TKR) segment is projected to dominate the market, primarily driven by the rising prevalence of osteoarthritis, particularly within the geriatric population. This trend underscores the growing demand for durable and effective therapeutic interventions such as TKR. Furthermore, enhanced healthcare infrastructure and increasing awareness of treatment options have facilitated broader accessibility to knee implants in both developed and emerging economies.

“The osteoarthritis & rheumatoid arthritis segment commanded the largest applications market share in 2024.”

The knee replacement surgery market is segmented by application: osteoarthritis & rheumatoid arthritis, degenerative disease, cancers, and other applications. In 2024, the osteoarthritis & rheumatoid arthritis segment held the major share. Degenerative joint diseases and inflammatory conditions, such as arthritis, can be exacerbated during their initial stages due to sedentary behavior, suboptimal postural alignment, and mechanical stress on the joints resulting from routine activities.

“The knee implants segment held the largest product market share in 2024.”

The knee implants segment represents the predominant share of the knee replacement surgery market. These implants are pivotal in enhancing patients' quality of life by providing long-lasting analgesia and restoring joint mobility. Their preference among orthopedic surgeons and patients alike can be attributed to their high success and satisfaction rates. Continuous advancements in materials—such as biocompatible alloys and polymers—coupled with innovative design enhancements and superior fixation techniques, have increased the reliability and longevity of these implants. Consequently, there has been a notable uptick in their adoption across various clinical settings.

“The hospitals segment accounted for the largest end user market share in 2024.”

Hospitals command the largest market share in knee treatment surgical products due to their central role in providing advanced and specialized interventions for knee pathologies. They are equipped to perform cutting-edge procedures, such as total knee arthroplasty, positioning themselves as the preferred venues for orthopedic surgeries. Furthermore, hospitals typically have the financial resources and infrastructure necessary to handle complex cases, execute minimally invasive techniques, and deliver comprehensive postoperative care, all of which contribute to sustained demand for knee treatment surgical devices.

“The Asia Pacific market is expected to register the highest growth rate during the forecast period.”

The knee replacement surgery market covers five key geographies—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, a significant market share for knee treatment surgery devices was held by the market in the North American region, comprising the US and Canada. On the other hand, the Asia Pacific market is estimated to register the highest growth rate during the forecast period. The Asia Pacific region is witnessing unprecedented expansion in the market for knee treatment surgical devices, driven by several key factors. The demographic shift towards an aging population is significant, with increased prevalence of musculoskeletal disorders such as arthritis and osteoporosis particularly evident in nations like Japan, China, and India. This demographic change is compounded by rising disposable incomes and improved access to healthcare services. The region's healthcare infrastructure is rapidly evolving, with investments in advanced technologies such as minimally invasive surgical techniques and robotic-assisted procedures, which are enhancing surgical outcomes and patient recovery times. Moreover, the surge in medical tourism, particularly in India and Thailand, along with proactive government initiatives aimed at bolstering healthcare infrastructure, further catalyzes market growth. These dynamics collectively position the Asia Pacific as a pivotal market for advancements in orthopedic treatment devices.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1– 30%, Tier 2– 42%, and Tier 3– 28%
• By Designation: Directors– 10%, Managers– 14%,and Others– 76%
• By Region: North America– 40%, Europe– 30%, Asia Pacific– 22%, Latin America- 6%, Middle East & Africa- 2%

The prominent players in the Knee replacement surgery market are Stryker (US), Johnson & Johnson Services, Inc. (US), Globus Medical, Inc. (US), Medacta International SA (Switzerland), Zimmer Biomet (US), Maxx Orthopedics (US), Enovis Corporation (US), Microport Scientific Corporation (China), B. Braun Melsungen AG (Germany), Meril Life Sciences Pvt. Ltd. (India), Smith & Nephew PLC (UK), and Exactech Inc. (US)

Research Coverage

This market research report analyzes the knee replacement surgery market along several different segments, such as procedure type, product, application, end user, and region. The report further sheds light on market growth-driving factors, mentions opportunities and threats, and presents an analysis of the competitive rivalry of leading companies. It further studies micro markets by focusing on growth tendencies and predicts revenues for industry segments for five leading geographies, along with corresponding countries.

Reasons to Buy the Report

The report would assist both small and new businesses in comprehending the market pattern, which can help them grow their market. Businesses procuring the report can implement any one or several of the approaches discussed to extend their market position.

This report provides insights on the following pointers:

• Key drivers (increasing prevalence of osteoarthritis and rheumatoid arthritis, Increasing adoption of telemedicine and telesurgery, rising demand for minimally invasive procedures, increasing demand for minimally invasive knee surgical procedures, and higher incidence of sports and accident-related orthopedic injuries), restraints (risk and complications associated with knee surgery procedures, high cost of knee treatment surgery and treatments), opportunities (Growing focus on orthobiologics, increasing hospitals and trend towards outpatient care and innovations in robotic-assisted orthopedic surgeries and 3D printing), and challenges (dearth of orthopedic surgeons ) fueling the market growth of knee treatment surgery devices
• Product Development/Innovation: In-depth study of emerging technologies, R&D programs, and new product & service launches in the knee replacement surgery market
• Market Growth: In-depth insights into remunerative markets report analyze the knee replacement surgery market across varied geographies.
• Market Diversification: Detailed analysis of new products, unexplored geographies, latest trends, and investments in the knee replacement surgery market
• Competitive Analysis: In-depth analysis of market shares, growth strategies, and services of leading players, such as Zimmer Biomet (US), Stryker (US), Johnson & Johnson Services, Inc. (US), Smith+Nephew PLC (UK), and B. Braun (Germany).

Show more